MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study. (October 2022)
- Record Type:
- Journal Article
- Title:
- MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study. (October 2022)
- Main Title:
- MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study
- Authors:
- Ou, S.H.
Moreno Garcia, V.
Gil Bazo, I.
Prenen, H.
Moreno, I.
Johnson, M.
Castañón Álvarez, E.
Nagasaka, M.
Adeyemi, S.
Barasa, B.
Bol, K.
Doze, P.
Engbers, A.
Joe, A.K.
Stalbovskaya, V.
Laus, G.
Call, J. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 174(2022)Supplement 1
- Journal:
- European journal of cancer
- Issue:
- Volume 174(2022)Supplement 1
- Issue Display:
- Volume 174, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 174
- Issue:
- 1
- Issue Sort Value:
- 2022-0174-0001-0000
- Page Start:
- S122
- Page End:
- Publication Date:
- 2022-10
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(22)01124-8 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24203.xml